Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PASSION: Symbicort Single Inhaler Therapy in Asthma
NCT00628758Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2005
- Primary completion
- Sep 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide in asthma, sponsored by AstraZeneca. Started Dec 2005; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00628758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00628758.